Skip to main content

ResMed| U.S., Canada and Latin America revenue

  • RMD · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$239.53+0.27%Close 13 Nov 2026 · Market value $33.91B

U.S., Canada and Latin America revenue at ResMed| came to $818.7M for the quarter to 31 Mar 2026, up 9.3% from a year earlier.

As ResMed| reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 1 May 2026.

By quarter

$578.1MSep 2022$615.3MDec 2022$629.1MMar 2023$638.4MSep 2023$669.3MDec 2023$687.5MMar 2024$707.3MSep 2024$748.9MDec 2024$749.3MMar 2025$774.8MSep 2025$835.0MDec 2025$818.7MMar 2026
ResMed| U.S., Canada and Latin America revenue, every reported period
Period endingU.S., Canada and Latin America revenueChange on a yearFiled
31 Mar 2026$818.7Mup 9.3%1 May 2026
31 Dec 2025$835.0Mup 11.5%30 Jan 2026
30 Sep 2025$774.8Mup 9.5%31 Oct 2025
31 Mar 2025$749.3Mup 9.0%24 Apr 2025
31 Dec 2024$748.9Mup 11.9%31 Jan 2025
30 Sep 2024$707.3Mup 10.8%25 Oct 2024
31 Mar 2024$687.5Mup 9.3%26 Apr 2024
31 Dec 2023$669.3Mup 8.8%25 Jan 2024
30 Sep 2023$638.4Mup 10.4%27 Oct 2023
31 Mar 2023$629.1Mup 32.3%28 Apr 2023
31 Dec 2022$615.3Mup 26.4%27 Jan 2023
30 Sep 2022$578.1M—28 Oct 2022
31 Mar 2022$475.4M—29 Apr 2022
31 Dec 2021$486.8M—28 Jan 2022

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of ResMed|: Devices revenue · Masks and other revenue · Residential Care Software revenue · United States revenue · Rest of the World revenue · Global revenue · Combined Europe, Asia and other markets revenue · financial statements

Every KPI and segment of RMD, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.